Corneal graft rejection

Ocular Disease: Mechanisms and Management

Volumn , Issue , 2010, Pages 56-63

  Saban, Daniel R ^a   Dastjerdi, Mohammad H ^a   Dana, Reza ^b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882488635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2983-7.00008-5     Document Type: Chapter

References (54)

1. Khodadoust AA, Silverstein AM Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol 1969, 8:180-195.
2. The Australian Corneal Graft Registry 2007 report Available online at. http://hdl.handle.net/2328/1723.
3. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994, 101:1536-1547.
4. Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992, 110:1392-1403. The collaborative corneal transplantation studies (CCTS), [No authors listed].
5. Cursiefen C, Chen L, Saint-Geniez M, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 2006, 103:11405-11410.
6. Masli S, Turpie B, Hecker KH, et al. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol 2002, 168:2264-2273.
7. Kaplan HJ, Streilein JW Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J Immunol 1977, 118:809-814.
8. Hamrah P, Dana MR Corneal antigen-presenting cells. Chem Immunol Allergy 2007, 92:58-70.
9. Huq S, Liu Y, Benichou G, et al. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol 2004, 173:4464-4469.
10. Yamagami S, Dana MR The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001, 42:1293-1298.
11. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 2004, 10:813-815.
12. Yamada J, Kurimoto I, Streilein JW Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 1999, 40:2614-2621.
13. Hegde S, Beauregard C, Mayhew E, et al. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation 2005, 79:23-31.
14. Beauregard C, Stevens C, Mayhew E, Niederkorn JY Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol 2005, 174:6577-6581.
15. Goslings WR, Yamada J, Dana MR, et al. Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci 1999, 40:250-253.
16. Kang PC, Klintworth GK, Kim T, et al. Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea 2005, 24:801-803.
17. Price FW, Whitson WE, Collins KS, et al. Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol 1993, 111:799-805.
18. 2006 Eye banking statistical report 2006, Eye Bank Association of America (EBAA), Eye Bank Association of America, Washington, DC.
19. Zirm E Eine erfolgreiche totale Keratoplastik [A successful total keratoplasty]. Albrecht von Graefes Arch Ophthalmol 1906, 64:580.
20. Paufique L, Sourdille GP, Offret G Les Greffes de la Cornée 1948, Masson, Paris.
21. Maumenee AE The influence of donor recipient sensitization on corneal grafts. Am J Ophthalmol 1951, 34:142-152.
22. Alldredge OC, Krachmer JH Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 1981, 99:599-604.
23. Krachmer JH, Alldredge OC Subepithelial infiltrates. A probable sign of corneal transplant rejection. Arch Ophthalmol 1978, 96:2234-2237.
24. Thompson RW, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003, 110:1396-1402.
25. Williams KA, Esterman AJ, Bartlett C, et al. How effective is penetrating corneal transplantation Factors influencing long-term outcome in multivariate analysis. Transplantation 2006, 81:896.
26. Vail A, Gore SM, Bradley BA, et al. Conclusions of the corneal transplant follow up study. Collaborating surgeons. Br J Ophthalmol 1997, 81:631-636.
27. Khodadoust AA The allograft rejection: the leading cause of late graft failure of clinical corneal grafts. Corneal Graft Failure. Ciba Foundation Symposium 15 1973, 151-164. Elsevier, Amsterdam. R. Porter, J. Knight (Eds.).
28. Coster DJ, Williams KA The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 2005, 140:1112.
29. Streilein JW, Toews GB, Bergstresser PR Corneal allografts fail to express Ia antigens. Nature 1979, 282:326-327.
30. Williams KA, Ash JK, Coster DJ Histocompatibility antigen and passenger cell content of normal and diseased human cornea. Transplantation 1985, 39:265-269.
31. Williams KA, Coster DJ The immunobiology of corneal transplantation. Transplantation 2007, 84:806-813.
32. Osawa H, Streilein JW MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes. Cornea 2005, 24:312-318.
33. Sonoda Y, Streilein JW Orthotopic corneal transplantation in mice - evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992, 54:694-704.
34. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192.
35. Lee HO, Herndon JM, Barreiro R, et al. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 2002, 169:4739-4744.
36. Sugita S, Streilein JW Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2003, 198:161-171.
37. Taylor AW, Streilein JW, Cousins SW Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992, 11:1199-1206.
38. Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991, 32:2201-2211.
39. Zhu S, Dekaris I, Duncker G, et al. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res 1999, 19:661-669.
40. Yamagami S, Hamrah P, Zhang Q, et al. Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. Mol Vis 2005, 11:632-640.
41. Zhu SN, Yamada J, Streilein JW, et al. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 2000, 69:1008-1013.
42. Chen L, Huq S, Gardner H, et al. Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol 2007, 125:783-788.
43. Cursiefen C Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy 2007, 92:50-57.
44. Sonoda A, Sonoda Y, Muramatu R, et al. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts. Invest Ophthalmol Vis Sci 2000, 41:790-798.
45. Sano Y, Okamoto S, Streilein JW Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes. Curr Eye Res 1997, 16:1171-1174.
46. Cursiefen C, Chen L, Dana MR, et al. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003, 22:273-281.
47. Regina M, Zimmerman R, Malik G, et al. Lymphangiogenesis concurrent with haemangiogenesis in the human cornea. Clin Exp Ophthalmol 2007, 35:541-544.
48. Jin Y, Shen L, Chong EM, et al. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 2007, 13:626-634.
49. Sano Y, Osawa H, Sotozono C, et al. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci 1998, 39:1953-1957.
50. Slegers TP, van der Gaag R, van Rooijen N, et al. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts. Curr Eye Res 2003, 26:73-79.
51. Niederkorn JY, Stevens C, Mellon J, et al. CD4+ T-cell-independent rejection of corneal allografts. Transplantation 2006, 81:1171-1178.
52. Hargrave SL, Hay C, Mellon J, et al. Fate of MHC- matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci 2004, 45:1188-1193.
53. Boisgérault F, Liu Y, Anosova N, et al. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol 2001, 167:1891-1899.
54. Niederkorn JY, Stevens C, Mellon J, et al. Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts. Am J Transplant 2006, 6:705-713.